Study met primary end point and demonstrated successful subcutaneous administration of a 10 mL biologic co-formulated with ENHANZE® in 30 seconds using Halozyme's proprietary high-volume auto-injector ...

A monthly injection has helped 90% of severe asthma patients reduce daily steroid tablets, which are associated with long-term side effects. More than half of the participants who had received the ...

VIENNA — Physicians are called to record clinical details of patients with asthma undergoing biologic therapy to monitor clinical remission and keep an eye on eosinophilic granulomatosis with ...

Monthly injection with tezepelumab helped 90% of patients with severe asthma reduce intake of daily steroid tablets. The corresponding study was published in The Lancet Respiratory Medicine. “In this ...

Biologic therapies have transformed the management of allergic asthma by targeting specific mediators of type 2 inflammation. These agents, principally monoclonal antibodies directed against ...

Please provide your email address to receive an email when new articles are posted on . Patients with comorbidities were more likely to initiate biologic treatment. Patients who adhered to treatment ...

The American College of Chest Physicians recently released a new clinical guideline on biologic management in severe asthma. Published in the journal CHEST, the guideline contains seven evidence-based ...

Asthma is a chronic respiratory condition that affects millions of people of all ages. While there is no cure, modern asthma medications make it possible for most people to control symptoms, prevent ...

Please provide your email address to receive an email when new articles are posted on . Data came from the FDA Adverse Event Reporting System from 2004 to 2024. Omalizumab had significant associations ...